Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Appendix B: Panel Roster and Financial Disclosures

Cryptosporidia/Microsporidia

Last Updated: August 1, 2019; Last Reviewed: August 1, 2019

Cryptosporidiosis and Microsporidiosis
Member Financial Disclosure
Company Relationship
Desruisseaux, Mahalia Albert Einstein College of Medicine None N/A
Didier, Elizabeth University of California, Davis None N/A
Hlavsa, Michele Centers for Disease Control and Prevention None N/A
Ward, Honorine Tufts University School of Medicine None N/A
Weiss, Louis* Albert Einstein College of Medicine  None N/A
White, A. Clinton University of Texas Medical Branch None N/A
Xiao, Lihua Centers for Disease Control and Prevention None N/A
* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines